$1.57
-0.03-1.88%
At Close: -
$1.59
0.021.27%
After Hours: Jul 3, 3:18 PM EDT
15 minutes delayed
Biodesix
BDSXNASDAQ
Biodesix (NASDAQ:BDSX) Stock, Analyst Ratings, Price Targets, Forecasts
Biodesix Inc has a consensus price target of $2.86 based on the ratings of 7 analysis. The 3 most-recent analyst ratings were released by TD Cowen, Lake Street, and Canaccord Genuity on May 13, 2024, May 3, 2024, and March 4, 2024, respectively. With an average price target of $3.1 between TD Cowen, Lake Street, and Canaccord Genuity, there's an implied 94.97% upside for Biodesix Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Lake Street
Canaccord Genuity
Morgan Stanley
Cowen & Co.
1calculated from analyst ratings
Analyst Ratings for Biodesix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | Buy Now | 76.1% | TD Cowen | Dan Brennan | → $2.8 | Initiates | → Buy | Get Alert |
| 05/03/2024 | Buy Now | 88.68% | Lake Street | — | → $3 | Initiates | → Buy | Get Alert |
| 03/04/2024 | Buy Now | 120.13% | Canaccord Genuity | Kyle Mikson | → $3.5 | Reiterates | Buy → Buy | Get Alert |
| 12/07/2023 | Buy Now | 120.13% | Canaccord Genuity | Kyle Mikson | → $3.5 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2022 | Buy Now | 214.47% | Morgan Stanley | Tejas Savant | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 04/20/2022 | Buy Now | — | Cowen & Co. | Max Masucci | — | Initiates | → Outperform | Get Alert |
| 11/17/2021 | Buy Now | 591.82% | Morgan Stanley | Tejas Savant | — | Downgrade | Overweight → Equal-Weight | Get Alert |
FAQ
What is the target price for Biodesix (BDSX) stock?
The latest price target for Biodesix (NASDAQ:BDSX) was reported by TD Cowen on May 13, 2024. The analyst firm set a price target for $2.80 expecting BDSX to rise to within 12 months (a possible 76.10% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biodesix (BDSX)?
The latest analyst rating for Biodesix (NASDAQ:BDSX) was provided by TD Cowen, and Biodesix initiated their buy rating.
When was the last upgrade for Biodesix (BDSX)?
There is no last upgrade for Biodesix
When was the last downgrade for Biodesix (BDSX)?
The last downgrade for Biodesix Inc happened on November 17, 2021 when Morgan Stanley changed their price target from $21 to $11 for Biodesix Inc.
When is the next analyst rating going to be posted or updated for Biodesix (BDSX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biodesix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biodesix was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
Is the Analyst Rating Biodesix (BDSX) correct?
While ratings are subjective and will change, the latest Biodesix (BDSX) rating was a initiated with a price target of $0.00 to $2.80. The current price Biodesix (BDSX) is trading at is $1.59, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.